Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02559778
Title Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Giselle Sholler
Indications

neuroblastoma

ganglioneuroblastoma

Therapies

Bortezomib

Crizotinib

Lapatinib

Vorinostat

Eflornithine

Sorafenib

Dasatinib

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.